NCT00598104View on ClinicalTrials.gov

Safety and Efficacy of QAX576 in Adults With Moderate Persistent Allergic Asthma

PHASE1/PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 31, 2008

Primary Completion Date

December 31, 2008

Conditions
Asthma
Interventions
DRUG

QAX576

DRUG

Placebo

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY